International Neuroblastoma Risk Group Consortium: A Model for Networking Rare Cancers

Strategic Insights -

Researchers from the International Neuroblastoma Risk Group (INRG) Task Force have made significant strides in advancing the understanding of neuroblastoma, a rare form of cancer. By sharing knowledge and harmonizing approaches, the INRG Task Force has achieved a remarkable level of progress in the field. The group's data-sharing model has led to the creation of the INRG Data Commons, which now houses information on over 25,000 patients, making it an essential resource for researchers worldwide. The INRG staging and risk classification systems have also contributed to the development of uniform criteria for classifying biological data, evaluating disease extent, and defining treatment response.

Key Takeaways:

  • The INRG Task Force was formed by four major neuroblastoma cooperative groups in 2004 to achieve a common goal of optimizing progress in rare cancers.
  • Funders for this research include the St Baldrick's Foundation, Rally Foundation for Childhood Cancer Research, Neuroblastoma Children's Cancer Society, and several other organizations.
  • The INRG Data Commons now houses information on over 25,000 patients, making it an essential resource for researchers worldwide.
  • The INRG staging and risk classification systems have led to harmonized approaches for therapeutic groupings and uniform criteria for classifying biological data.
  • More than 40 INRG research studies have been performed by investigators from around the world, including analyses of rare patients, which would not otherwise be possible.
  • The international networking model developed by the INRG Task Force has led to new research discoveries and progress in neuroblastoma.
  • The approach has now been applied to 16 other cancers and conditions, including rhabdomyosarcoma, germ cell tumor, Lynch syndrome, and cancer predisposition.
  • The INRG framework serves as a model for advancing rare adult malignancies.

Statistics:

  • 25,042 patients have information available to the research community through the INRG Data Commons.
  • 40 INRG research studies have been performed by investigators from around the world.
  • The INRG Task Force was formed in 2004 by four major neuroblastoma cooperative groups.
  • Over $10 million has been funded by organizations like the St Baldrick's Foundation and Rally Foundation for Childhood Cancer Research.
  • 8800 patients were initially transferred to the INRG Data Commons in the initial cohort.
  • The INRG stage 1 and 2 protocols have helped expand treatment options for neuroblastoma patients worldwide.

Sources:

  • NewsRx. Study Data from Royal Marsden Hospital Update Understanding of Neuroblastomas (International Neuroblastoma Risk Group Consortium: a Model of Networking for Rare Cancers). Cancer Weekly. October 21, 2025; p 901.
  • International Neuroblastoma Risk Group Consortium: a Model of Networking for Rare Cancers. JNCI: Journal of the National Cancer Institute, 2025.
  • Oxford Univ Press Inc, Journals Dept, 2001 Evans Rd, Cary, NC 27513, USA.
  • Royal Marsden NHS Foundation Trust, Institute for Cancer Research, Downs Rd, London SM2 5PT, United Kingdom.
  • Andrew D. J. Pearson, et al. International Neuroblastoma Risk Group Consortium: a Model of Networking for Rare Cancers. JNCI: Journal of the National Cancer Institute, 2025.
  • St Baldrick's Foundation
  • Rally Foundation for Childhood Cancer Research
  • Neuroblastoma Children's Cancer Society
  • Sammy's Superheroes
  • Matthew Bittker Foundation
  • Children's Cancer Research Fund
  • Little Heroes Pediatric Cancer Foundation
  • Alex's Lemonade Stand Foundation
  • William Guy Forbeck Research Foundation.